BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2002
View Archived Issues
Posaconazole effective against Aspergillus fumigatus in vitro and in vivo
Read More
Antiproliferative effects of selenomethionine in human prostate cancer cells
Read More
MT-100 well tolerated over one-year period
Read More
GenOdyssee's interferon variants show preclinical potential in hepatitis C and cancer
Read More
Pro-Pharmaceuticals to advance Davanat-1 into clinic in fourth quarter
Read More
Diacrin and Terumo sign muscle cell transplantation technology agreement for Japan
Read More
Cubist and Gilead's European commercialization agreement for Cidecin terminated
Read More
Cytotoxicity of CHS-828 enhanced in PARP-1-deficient mouse fibroblasts
Read More
Melacine rights return to Corixa
Read More
Herbal complex safe and effective for the treatment of IBS
Read More
Cardioprotective effect and mechanisms of Bay-11-7085 explored
Read More
PARS (PARP) activation implicated in autoimmune islet beta-cell destruction in NOD mice
Read More
Ezetimibe + statin effective and safe in hypercholesterolemic patients with type 2 diabetes
Read More
Potent, well-tolerated PDE4 inhibitor with suitable PK profile selected for development at Merck
Read More
Selective inverse agonist at GABA-A alpha5 receptor subtype enhances cognition in rats
Read More
Milnacipran phase II trial in FMS completes enrollment ahead of schedule
Read More
Avastin fails to meet primary endpoint in phase III metastatic breast cancer trial
Read More
Considerable progress reported by Xenova in first six months of 2002
Read More
Novel antibacterial carbapenems prepared and tested at Banyu
Read More
New FTase inhibitors for cancer and other conditions claimed by Servier
Read More
Wyeth and ArQule present novel inhibitors of Abeta production
Read More
New NPY receptor modulators and their use in obesity, diabetes, etc.
Read More
Antiprotozoal and antiretroviral compounds identified by French researchers
Read More
Akzo Nobel designs new GABA-A modulators for use as sedatives, analgesics
Read More
Novel agents for stimulating melanocyte proliferation covered by BTG patent
Read More